Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway.
暂无分享,去创建一个
P. Byers | V. McKusick | H. Hoyme | R. Pyeritz | U. Schwarze | R. Hata | H. Shinkai
[1] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[2] C. Attanasio,et al. Outcome of donor splice site mutations accounting for congenital afibrinogenemia reflects order of intron removal in the fibrinogen alpha gene (FGA). , 2003, Blood.
[3] P. Byers,et al. Order of intron removal influences multiple splice outcomes, including a two-exon skip, in a COL5A1 acceptor-site mutation that results in abnormal pro-alpha1(V) N-propeptides and Ehlers-Danlos syndrome type I. , 2002, American journal of human genetics.
[4] D. Bentley. The mRNA assembly line: transcription and processing machines in the same factory. , 2002, Current opinion in cell biology.
[5] J. Schalkwijk,et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. , 2001, The New England journal of medicine.
[6] M. Garcia-Blanco,et al. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. , 2001, Gene.
[7] W. Cole,et al. COL5A1 Exon 14 Splice Acceptor Mutation Causes a Functional Null Allele, Haploinsufficiency of α1(V) and Abnormal Heterotypic Interstitial Fibrils in Ehlers-Danlos Syndrome II* , 2001, The Journal of Biological Chemistry.
[8] A. Green,et al. A novel mutation and novel features in Nijmegen breakage syndrome , 2001, Journal of medical genetics.
[9] L. Maquat,et al. Quality Control of mRNA Function , 2001, Cell.
[10] J. Mcneil,et al. Tracking Col1a1 RNA in Osteogenesis Imperfecta , 2000, The Journal of cell biology.
[11] W. Cole,et al. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. , 2000, American journal of human genetics.
[12] P. Byers,et al. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II). , 2000, American journal of human genetics.
[13] L. Lagae,et al. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. , 2000, American journal of human genetics.
[14] C. Giunta,et al. Compound heterozygosity for a disease-causing G1489E [corrected] and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability? , 2000, American journal of medical genetics.
[15] P. Byers,et al. Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. , 1999, American journal of human genetics.
[16] R. G. Keene,et al. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes. , 1999, Nucleic acids research.
[17] N. Burrows,et al. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. , 1998, Journal of medical genetics.
[18] K. Michalickova,et al. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. , 1998, Human molecular genetics.
[19] M. Roth,et al. Transcription units as RNA processing units. , 1997, Genes & development.
[20] M. Ares,et al. Intron self-complementarity enforces exon inclusion in a yeast pre-mRNA. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Bristow,et al. Tenascin–X deficiency is associated with Ehlers–Danlos syndrome , 1997, Nature Genetics.
[22] M. Roth,et al. Distribution of pre-mRNA splicing factors at sites of RNA polymerase II transcription. , 1997, Genes & development.
[23] J. Naeyaert,et al. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. , 1997, American journal of human genetics.
[24] D. Greenspan,et al. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. , 1996, Journal of medical genetics.
[25] W. Cole,et al. A Splice-Junction Mutation in the Region of COL5A1 that Codes for the Carboxyl Propeptide of Proα1(V) Chains Results in the Gravis Form of the Ehlers-Danlos Syndrome (Type I) , 1996 .
[26] S. Berget. Exon Recognition in Vertebrate Splicing (*) , 1995, The Journal of Biological Chemistry.
[27] L. Chasin,et al. Order of intron removal during splicing of endogenous adenine phosphoribosyltransferase and dihydrofolate reductase pre-mRNA , 1993, Molecular and cellular biology.
[28] D. Libri,et al. Pre‐mRNA secondary structure and the regulation of splicing , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.
[29] M T Davisson,et al. Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] G. B. Knight,et al. Ordered splicing of thymidine kinase pre-mRNA during the S phase of the cell cycle , 1990, Molecular and cellular biology.
[31] S. Kurata,et al. Existence of malfunctioning proα2(I) collagen genes in a patient with a proα2(I)‐chain‐defective variant of Ehlers‐Danlos syndrome , 1988 .
[32] S. Okamoto,et al. Case Report and Study of Collagen Metabolism in Ehlers‐Danlos Syndrome Type II , 1988, The Journal of dermatology.
[33] R. Spritz,et al. In vitro splicing pathways of pre-mRNAs containing multiple intervening sequences? , 1987, Molecular and Cellular Biology.
[34] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[35] R. Spritz,et al. The two intervening sequences of human beta‐ and gamma‐globin pre‐mRNAs are excised in a preferred temporal order in vitro. , 1985, The EMBO journal.
[36] P. Byers,et al. Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. , 1985, The Journal of biological chemistry.
[37] T. Pihlajaniemi,et al. Osteogenesis imperfecta: cloning of a pro-alpha 2(I) collagen gene with a frameshift mutation. , 1984, The Journal of biological chemistry.
[38] F. Pope,et al. BIOCHEMICAL HETEROGENEITY OF OSTEOGENESIS IMPERFECTA: NEW VARIANT , 1979, The Lancet.
[39] P. Byers,et al. Abnormal collagen fibril structure in the gravis form (type I) of Ehlers-Danlos syndrome. , 1979, Laboratory investigation; a journal of technical methods and pathology.
[40] A. Schuurs,et al. HEPANOSTICON IN SCREENING FOR HBsAg , 1975, The Lancet.
[41] S. Wallis,et al. Homozygosity for a splice site mutation of the COL1A2 gene yields a non-functional pro(alpha)2(I) chain and an EDS/OI clinical phenotype. , 2001, Journal of medical genetics.
[42] Beat Steinmann,et al. Connective tissue and its heritable disorders —Molecular, genetic and medical aspects , 1993 .
[43] S. Berget,et al. Exon definition may facilitate splice site selection in RNAs with multiple exons. , 1990, Molecular and cellular biology.
[44] T. Sasaki,et al. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen. , 1987, Archives of dermatology.